Metraipolis › archive › dc_65bba3ac925c
Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer — Europe PMC PMID:33092442
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33092442
- DOI
- 10.1080/21655979.2020.1834726
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T10:47:04.067Z
- SHA-256 of the archived text
eff920dcf50fde6a2d7f5669b1dbb6387eaae7026663522a84e569663802d2fb- Stable URL of this page
https://metraipolis.com/documento/dc_65bba3ac925c
How to cite
Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer — Europe PMC PMID:33092442 — Europe PMC (en), https://europepmc.org/article/MED/33092442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_65bba3ac925c (Metraipolis archive dc_65bba3ac925c, sha256 eff920dcf50fde6a2d7f5669b1dbb6387eaae7026663522a84e569663802d2fb)
BibTeX
@misc{dc65bba3ac925c,
title = {Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer — Europe PMC PMID:33092442},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33092442},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_65bba3ac925c; sha256 eff920dcf50fde6a2d7f5669b1dbb6387eaae7026663522a84e569663802d2fb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/33092442. Agents can read the archived copy with the MCP tool read_document.